- Home
- QURE vs BLMN Comparison
QURE vs BLMN Comparison
Compare QURE & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- BLMN
- Stock Information
- Founded
- QURE 1998
- BLMN 1988
- Country
- QURE Netherlands
- BLMN United States
- Employees
- QURE N/A
- BLMN N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- BLMN Restaurants
- Sector
- QURE Health Care
- BLMN Consumer Discretionary
- Exchange
- QURE Nasdaq
- BLMN Nasdaq
- Market Cap
- QURE 725.4M
- BLMN 736.6M
- IPO Year
- QURE 2007
- BLMN 2012
- Fundamental
- Price
- QURE $15.85
- BLMN $7.30
- Analyst Decision
- QURE Strong Buy
- BLMN Hold
- Analyst Count
- QURE 10
- BLMN 10
- Target Price
- QURE $36.90
- BLMN $10.44
- AVG Volume (30 Days)
- QURE 1.2M
- BLMN 3.1M
- Earning Date
- QURE 07-29-2025
- BLMN 08-06-2025
- Dividend Yield
- QURE N/A
- BLMN 8.57%
- EPS Growth
- QURE N/A
- BLMN N/A
- EPS
- QURE N/A
- BLMN N/A
- Revenue
- QURE $14,337,000.00
- BLMN $3,933,993,000.00
- Revenue This Year
- QURE N/A
- BLMN $1.00
- Revenue Next Year
- QURE $278.91
- BLMN $1.45
- P/E Ratio
- QURE N/A
- BLMN $7.77
- Revenue Growth
- QURE N/A
- BLMN 2.47
- 52 Week Low
- QURE $4.45
- BLMN $6.09
- 52 Week High
- QURE $19.18
- BLMN $18.72
- Technical
- Relative Strength Index (RSI)
- QURE 62.03
- BLMN 39.08
- Support Level
- QURE $12.89
- BLMN $6.39
- Resistance Level
- QURE $16.66
- BLMN $7.32
- Average True Range (ATR)
- QURE 0.85
- BLMN 0.56
- MACD
- QURE 0.26
- BLMN -0.12
- Stochastic Oscillator
- QURE 80.11
- BLMN 25.00
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About BLMN Bloomin' Brands Inc.
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.